Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-727-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
There is no reliable and relevant information source in which the toxicokinetic properties (absorption, distribution, metabolism, elimination) of CHIMEXANE NB were investigated. The expected toxicokinetic behaviour is derived from the physicochemical properties and the results from the available toxicological data following the guide given in the REACH guidance document R.7c.
Key value for chemical safety assessment
Additional information
There is no reliable and relevant information source in which the toxicokinetic properties (absorption, distribution, metabolism, elimination) of CHIMEXANE NB were investigated. The expected toxicokinetic behaviour is derived from the physicochemical properties and the results from the available toxicological data following the guide given in the REACH guidance document R.7c.
CHIMEXANE NB is a substance composed of constituents having a molecular weight of 343, 416 and 490. It is a yellow viscous liquid with estimated water solubility at 3.80 mg/L, above this concentration micelle formation occurs (micellular solubilisation). Vapour pressure was calculated to be about 0.00082 Pa at 20 °C and it has high lipophilic properties (for the three main constituents, log Kow > 4, log Kow= 5.5 for the multiconstituent substance CHIMEXANE NB).The surface tension is 29.63 mN/m.Detailed information can be found in section 4 of CHIMEXANE NB IUCLID dossier.
Absorption:
In acute toxicity studies, either by oral or dermal route, no systemic toxic effects were observed. Only local effects such as moderate-severe erythema associated with slight to moderate oedema, showing skin irritancy properties of the substance, were identified. In a reproduction/developmental toxicity screening test and in a 4-week repeated dose toxicity study by oral route, the main effects elicited by the substancewere transient reduced body weight gain and food consumption, reduced total cholesterol concentration in both males and females, and lower mean glucose level and mean creatinine valuesin females. These observations indicate partial bioavailability of CHIMEXANE NBviaoral route.
Although no signs of toxicity were observed in an acute dermal toxicity study, CHIMEXANE NB has a molecular weight < 500 and is a high lipophilic substance (main constituents with log Kow > 4) therefore dermal absorption is expected.
Thus, indications of oral and dermal uptake of CHIMEXANE NB are given. Therefore the bioavailability of CHIMEXANE NB can be considered to be existent but maybe limited.
Distribution:
The physico-chemical information (molecular weights < 500, lipophilicity and low water solubility) indicates that CHIMEXANE NB could be distributed to many tissues and, due to its lipophilicity, may have a particular affinity for fatty tissues.
Metabolism:
No data are available but, in in vitro genotoxicity studies (particularly in MLA test), differences in cytotoxicity were observed with and without metabolic activation. This indicates that CHIMEXANE NB may be metabolized by hepatic microsomal fractions.
Excretion:
As no toxic effects were observed in kidneys in repeated toxicity studies, it is difficult to determine if CHIMEXANE NB is excreted in urine. However, based on the physico-chemical information (low molecular weight and low water solubility), renal excretion of CHIMEXANE NB and/or its metabolites cannot be excluded.
Accumulative potential:
Based on some toxicological studies that provide indications on CHIMEXANE NB absorption and metabolism (repeated dose toxicity study and genotoxicity studies) and on physico-chemical information (molecular weights < 500 and log Kow >4), it is concluded that CHIMEXANE NB is partially bioavailable, it is also likely to be metabolized by hepatic enzymes and excreted. Therefore, the potential for bioaccumulation is expected to be low.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.